Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Hongbo Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0954-5600; OpenAlex author ID A5100452325. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. The prognostic value of myosteatosis in pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.1016/j.clnu.2024.10.017↗
  2. Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness. Co-author DOI 10.1038/s41419-019-1956-8↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qi Miao · 1 shared paper, 2024 · strength 0.24
  2. Keke Liang · 1 shared paper, 2024 · strength 0.24
  3. Lirong Zhang · 1 shared paper, 2019 · strength 0.09
  4. Aihua Gong · 1 shared paper, 2019 · strength 0.09
  5. Yanfang Liu · 1 shared paper, 2019 · strength 0.09
  6. Xin Fan · 1 shared paper, 2019 · strength 0.09
  7. Haitao Zhu · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.